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Takashi ShigematsuI am very honored to write this editorial for the launch of
Renal Replacement Therapy (RRT) and sincerely welcome
you to this new journal published by the Japanese Society
for Dialysis Therapy (JSDT) in collaboration with BioMed
Central. The JSDT aims to promote advances in technology
and research and the dissemination of knowledge related to
renal replacement medicine [1]. The main incentive to
launch this new international journal is the sense of crisis
acknowledged by the Society regarding the current status
of renal replacement therapy research.
Chronic renal replacement therapy mainly consists of
hemodialysis (HD) in Japan, which has been the preferred
option for national medical insurance since 1972. This
provides us with a rich history for near half a century. The
number of patients undergoing chronic renal replacement
therapy continually increases throughout Japan, which
includes almost 310,000 patients at the end of 2012 [2].
This number becomes a significant problem within the
national health management and medical economy.
Therefore, we should aim to focus on the management of
patients undergoing renal replacement therapy to contrib-
ute to their long life while also ensuring good quality of
life. These efforts could provide a huge impact on national
and world healthcare and medical economy fields. We
must also consider research into the most effective
medical interventions before renal replacement therapy
initiation becomes necessary. When it comes to prac-
ticing renal replacement therapy, Japan is an extremely
experienced country, and the treatment result out-
comes are among the most effective in the world [3].
We strongly consider that Japan’s wealth of valuable
experiences and strong research contributions should
be shared and should stimulate discussion all over the
world. This is the main reason to launch the new jour-
nal widely surrounding the knowledge and skills of
renal replacement therapy. The journal title “Renal Re-
placement Therapy (RRT)” is a simple and beautifulCorrespondence: taki@wakayama-med.ac.jp
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toneal dialysis (PD), blood purification technology, and
many complications seen at end-stage renal disease.
Both kidney transplantation and regenerative medicine
are within the remit of Renal Replacement Therapy. In
addition, both chronic kidney disease (CKD) and acute
kidney injury (AKI) are very important issues within
the journal scope. We welcome submissions from all
scientific fields related to renal replacement therapies
and from all countries and areas all over the world.
We also recognize the importance of providing a
quick peer-review process for our authors. The journal
operates a traditional closed peer-review system, and
two or more reviewers are consulted for each submis-
sion that proceeds to peer review. Peer review is con-
ducted by our experienced Editorial Board members
with the Renal Replacement Therapy policy of offering
a rapid, high-quality peer-review system. We shall pur-
sue to improve the journal standing in the field by both
publishing high-quality articles and providing con-
structive peer-review processes.
To realize the idealistic purpose of the new journal, we
decided to initiate this journal publication in collaboration
with BioMed Central [4]. We believe that open-access, on-
line journals have the most potential to approach a larger
set of active readers than traditional paper-based journals
[5]. We hope that our decision could lead to increased dis-
cussions, browsing, reading, and citations. This advantage
may allow our journal to be indexed in PubMed Central
and PubMed in no time at all. We are aiming to receive a
high-impact factor in order to place RRT as one of the top
journals in nephrology, renal replacement therapy, and
blood purification fields, as soon as we are eligible for
evaluation. The Society has also taken the decision to
cover the publication costs for all authors, who still retain
copyright. This means that all publication costs for articles
published in Renal Replacement Therapy are currently
covered by JSDT, and you will therefore not have to pay
an article-processing charge for this manuscript.is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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but also all developed countries and increases the inci-
dences for aging-induced kidney disease and end-stage
renal disease (ESRD) [6]. The amount of ESRD patients
requiring renal replacement therapy is also increasing,
and we see this trend within populations within develop-
ing countries as well [7]. Based on the current situation,
we are expecting a lot of new submissions to our journal
from all over the world, especially developing countries,
and the free publication fee aims to place RRT as a plat-
form for this research.
We wish to contribute a worldwide open discussion and
progression around renal replacement therapy areas. You
can hold copyright and grant anyone the right to reproduce
and disseminate your article in CC (Creative Commons)-
BY licenses under the most free of conditions [8]. Finally,
we also will submit several Society statement position pa-
pers as the Japanese Guidelines and Japanese Best Practice
documents around renal replacement therapy fields in RRT
in the near future.
We have been assessing and reviewing several manu-
scripts since accepting submissions to the journal a few
months ago. We have made a lot of effort to attract topical
research and informative review articles, which will soon
be published on the journal in the months following the
launch of the journal.
We hope you will consider contributing to our new
journal Renal Replacement Therapy.
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